Investigation for novel COVID-19 severity factors using human in vitro pathological models and clinical specimens

Investigation for novel COVID-19 severity factors using human in vitro pathological models and clinical specimens - Investigation for novel COVID-19 severity factors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045567

Enrollment

100

Registered

2021-10-01

Start date

2021-09-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients at 20 year-old or older with COVID-19 diagnosed by PCR methods.

Exclusion criteria

Exclusion criteria: Minors or patients who cannot give consent.

Design outcomes

Primary

Measure	Time frame
COVID-19 severity factors	—

Secondary

Measure	Time frame
Immune response to SARS-CoV-2 infection	—

Countries

Japan

Contacts

Public ContactKohei Fujita

NHO Kyoto Medical Center Respiratory Medicine

kfujita.acd@gmail.com0756419161

Outcome results